Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.

Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.

Item
http://www.wikidata.org/entity/Q43686454
Best clinical practice in botulinum toxin treatment for children with cerebral palsyEvaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.GRIN: "GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial": study protocol.Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects.Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.Off label use of botulinum toxin in children under two years of age: a systematic reviewSafety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.The cerebral palsy transition clinic: administrative chore, clinical responsibility, or opportunity for audit and clinical research?Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy.Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study.
P2860

Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.

Item
http://www.wikidata.org/entity/Q43686454
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Systemic adverse events follow ...... children with cerebral palsy.
@en
Systemic adverse events follow ...... children with cerebral palsy.
@nl
type
label
Systemic adverse events follow ...... children with cerebral palsy.
@en
Systemic adverse events follow ...... children with cerebral palsy.
@nl
prefLabel
Systemic adverse events follow ...... children with cerebral palsy.
@en
Systemic adverse events follow ...... children with cerebral palsy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Systemic adverse events follow ...... n children with cerebral palsy
@en
P2093
P304
P31
P356
10.1111/J.1469-8749.2009.03583.X
P433
P478
P50
P577
P5875
P698